A prospective randomized trial comparing piperacillin/tazobactam with meropenem as empirical antibiotic treatment of febrile neutropenic children and adolescents with hematologic and malignant disorders-Reference-Cited by-同舟云学术

A prospective randomized trial comparing piperacillin/tazobactam with meropenem as empirical antibiotic treatment of febrile neutropenic children and adolescents with hematologic and malignant disorders

Published:2016-11-22 Issue:6 Volume:64 Page:e26360
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr Blood Cancer

Author:

Sano Hirozumi¹,Kobayashi Ryoji¹,Suzuki Daisuke¹,Hori Daiki¹,Kishimoto Kenji¹,Kobayashi Kunihiko¹

Affiliation:

1. Department of Pediatrics; Sapporo Hokuyu Hospital; Shiroishi-ku Sapporo Japan

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference27 articles.

1. Cost-effectiveness of cefepime + netilmicin or ceftazidime + amikacin or meropenem monotherapy in febrile neutropenic children with malignancy in Turkey;Agaoglu;J Chemother,2001

2. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison;Corapcioglu;Pediatr Hematol Oncol,2006

3. Imipenem in the treatment of febrile neutropenic children;Erbey;Asian Pac J Cancer Prev,2009

4. Piperacillin/tazobactam versus cefepime for the empirical treatment of pediatric cancer patients with neutropenia and fever: a randomized and open-label study;Uygun;Pediatr Blood Cancer,2009

5. Meropenem monotherapy as an empirical treatment of febrile neutropenia in childhood cancer patients;Erbey;Asian Pac J Cancer Prev,2010

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of bacteremia at first-line antibiotic treatment for febrile neutropenia in children and adolescents: A retrospective, single-center analysis;Journal of Infection and Chemotherapy;2024-07

2. Use of cefepime, meropenem, or piperacillin/tazobactam as initial treatment for febrile neutropenia in patients with hematological malignancy — a real-life experience;The Egyptian Journal of Internal Medicine;2022-08-19

3. Comparison of the Efficacy of Piperacillin/Tazobactam and Meropenem, with or without Intravenous Immunoglobulin, as Second-Line Therapy for Febrile Neutropenia: A Prospective, Randomized Study;Clinical Pediatric Hematology-Oncology;2021-10-31

4. Efficacy of liposomal amphotericin against febrile neutropenia in pediatric patients receiving prophylactic voriconazole;Pediatrics International;2021-03-27

5. Meropenem versus piperacillin/tazobactam for febrile neutropenia in pediatric patients: efficacy of piperacillin/tazobactam as a 1-h drip infusion four times a day;International Journal of Hematology;2020-11-10